TERMINATION OF RESEARCH AGREEMENT. In the event that the above agreement is terminated, the advisor and student must complete this section. Signature of Research Advisor: Date: Signature of Student: Date: Signature of Co-Advisor (if applicable) Date: Reason for Termination: (attach any backup correspondence, if applicable)
TERMINATION OF RESEARCH AGREEMENT. Pegas agrees not to terminate, or cause the termination of, the Research Agreement to be entered into pursuant to Section 3.1, or any substitute research agreement entered into pursuant to Section 3.5, if applicable, prior to the second anniversary of the Effective Date, except as provided in either (i) Section 3.5 above or (ii) as a result of a material failure by The University of Arizona, or the Veterans Administration Medical Center, Tucson, Arizona, or any non-Affiliate nonprofit academic institution of which Xx. Xxxxxxx becomes a full-time employee, if applicable pursuant to Section 3.5, or Xx. Xxxxxxx to comply with the provisions of the Research Agreement or any substitute research agreement, if applicable, which failure has not been cured within thirty (30) days after a written notice thereof by Pegas. if Pegas terminates the Research Agreement by reason of Xx. Xxxxxxx'x failure to comply, as provided in (ii) above, Pegas, obligations under this Article 3 shall terminate as of the effective date of such termination. It is understood, however, that Pegas' obligation under Section 3.4 above to make available to Xx. Xxxxxxx the equipment described therein shall not terminate by reason of a termination of the Research Agreement under Section 3.5 above.
TERMINATION OF RESEARCH AGREEMENT. Amended ROFR;
TERMINATION OF RESEARCH AGREEMENT. As of the Effective Date, (1) the --------------------------------- Research Agreement and all licenses and other rights granted or conveyed therein shall terminate, except as set forth in Section 2.1(b) and (c) below and in Paragraph 8.06 of the Research Agreement and (2) Immunex shall cease funding of all oncology research and development by Wyeth and its Affiliates thereunder. Immunex has paid AHP a total of Eight Million Two Hundred Fifty-Eight Thousand Thirty- Three Dollars ($8,258,033) in funding for such oncology research and development for the period from January 1, 1998 through June 30, 1998. Such payment amount fully satisfies Immunex's payment obligations under Article 3 of the Research Agreement.
TERMINATION OF RESEARCH AGREEMENT. 4.1 The Research Agreement is hereby terminated and of no further force and effect, except as provided in Section 6.2 of this MoU, and except that Section 3.1 (other than (c)(iv)), Article 5 (Patent Prosecution and Defense) (except as amended by Section 6.3 of this MoU), 7 (Representation and Warranties), 8 (Indemnification), and 9 (Confidentiality) of the Research Agreement shall survive.
TERMINATION OF RESEARCH AGREEMENT. The parties hereby acknowledge and agree that the Research Agreement shall expire by its terms on September 30, 1996. In the event of a conflict between the terms of this Agreement and the Research Agreement and/or the License Agreement, the terms of this Agreement shall control.
